This is a powerful medicine used to treat certain types of cancer. It works by blocking a protein that helps tumors grow. It's usually given as an injection.
Every report comes from a Lived member, sent anonymously.
Have you tried Avastin (Bevacizumab) for Colorectal Cancer?
Bevacizumab, best known by the brand name Avastin, is a cancer medicine given by IV infusion. It is approved for several advanced cancers, usually alongside chemotherapy or another cancer drug: colorectal cancer that has spread, a common type of lung cancer (non-squamous non-small cell lung cancer), advanced kidney cancer, cervical cancer, ovarian, fallopian tube and primary peritoneal cancers, and liver cancer (hepatocellular carcinoma, where it is paired with the immunotherapy drug atezolizumab). It is also used on its own for glioblastoma, an aggressive brain tumor, when the tumor has come back. Several biosimilars, such as Mvasi and Zirabev, are approved in the US. A biosimilar is a near-identical version of a biologic medicine that the US Food and Drug Administration (FDA) has judged to work the same way, and your cancer center may use one in place of Avastin. Bevacizumab is also used in a very different way: a tiny dose is injected into the eye to treat wet age-related macular degeneration (AMD), in which leaky blood vessels grow under the retina and blur central vision. Eye doctors have long used repackaged Avastin for this off-label, meaning outside its approved uses, and also for related problems such as swelling of the retina from diabetes. In 2026 the FDA approved Lytenava, a bevacizumab product made specifically for eye injection in wet AMD.
Tumors need a blood supply to grow beyond a small size, and many send out a signal protein called VEGF (vascular endothelial growth factor) that prompts new blood vessels to sprout toward them. Bevacizumab is a lab-made antibody that latches onto VEGF and stops it from reaching its receptors, so fewer new vessels form. This can slow the growth and spread of a tumor, and it may help chemotherapy work, but it does not kill cancer cells directly. That is why it is usually given in combination rather than alone. The same signal drives the abnormal, leaky vessels in wet AMD. When bevacizumab is injected into the eye, it calms that leakage and swelling, which helps preserve central vision. Because VEGF also helps maintain normal blood vessels, wound healing and kidney filtering, blocking it throughout the body explains many of the side effects of the IV form, such as higher blood pressure, bleeding and slower wound healing.
For cancer, bevacizumab is given as an IV infusion at an infusion center every two or three weeks, depending on the cancer and the drugs it is paired with. The dose is calculated from body weight. The first infusion runs about 90 minutes; if it goes smoothly, the next one is shortened to about 60 minutes and later ones to about 30. Treatment usually continues in cycles for as long as it is helping and side effects stay manageable, and for some ovarian cancers it continues alone after chemotherapy ends. For the eye, an ophthalmologist numbs and cleans the eye and gives a small injection into the gel inside it, often about once a month at first. Vision may be blurry afterward from the drops and exam, so arrange a ride home.
With IV treatment, common side effects include high blood pressure, nosebleeds, headache, a runny nose, changes in taste, dry skin, watery eyes and back pain. Blood pressure often rises enough to need medicine, which is one reason it is checked regularly. Protein can also leak into the urine, usually without symptoms, and is found on routine urine tests. Reactions during the infusion, such as wheezing, chest tightness or chills, are uncommon and are managed by the infusion staff. Four less common risks are serious and specific to this drug. Contact the care team right away, the same day, if you notice signs of any of them. A tear in the bowel (perforation), which most often happens in the first two months, can cause severe or ongoing belly pain, fever with shaking chills, repeated vomiting or severe constipation. Serious bleeding can occur in different parts of the body, so report any unusual or heavy bleeding. Blood clots are more likely, and a clot in a leg vein typically causes a painful, swollen leg. A rare brain swelling linked to high blood pressure can cause a new severe headache, confusion or a change in vision. Some signs need emergency care instead. Call 911 for chest pain, sudden shortness of breath, pain when breathing in, sudden weakness or numbness on one side, or sudden trouble speaking, which can mean a clot has caused a heart attack or stroke or has traveled to the lungs. Also call 911 for a seizure, bleeding that will not stop, or coughing up blood. After an eye injection, vision can be blurry for a while. In the days that follow, an eye that becomes increasingly red, painful or sensitive to light, or a drop in vision, can mean infection or a detached retina; contact the eye doctor right away (the same day).
For people receiving IV treatment for cancer, surgery needs planning: bevacizumab slows wound healing, so it is generally stopped at least 28 days before planned surgery and not restarted until at least 28 days after major surgery and until the wound has healed. Tell any surgeon or dentist planning a procedure that you receive it. People who have recently coughed up blood are generally not given it, and the oncology team will weigh it carefully for anyone with recent bleeding, clots, heart failure or poorly controlled blood pressure. IV bevacizumab can harm a developing baby. People who could become pregnant should use effective birth control during treatment and for 6 months after the last dose, and should not breastfeed during that time. It can also cause the ovaries to stop working in premenopausal women, and ovarian function may not return after treatment ends, so it is worth discussing fertility and egg-freezing options before starting. For eye injections, the approved eye product advises effective birth control during treatment and for at least 3 months after the last injection, and anyone pregnant, planning a pregnancy or breastfeeding should tell the eye doctor. It does not have many direct drug interactions, but because it is combined with chemotherapy, the care team should know about every medicine and supplement you take, especially blood thinners and pain relievers that affect bleeding.
Bevacizumab is part of a larger cancer treatment plan, and its effect is judged with scans over months rather than by how you feel after an infusion. When it works, the usual goal is to slow the cancer and keep it controlled longer; it is not a cure on its own, and how much it helps varies by cancer type and person. Each visit typically includes a blood pressure check, and urine is tested for protein on a regular schedule. If blood pressure or urine protein climbs, treatment may be paused while it is brought under control. Blood pressure can stay elevated for a while after treatment stops, so keep checking it. For wet AMD, many people keep their vision steady and some gain back part of what they lost. In head-to-head trials, bevacizumab worked about as well as ranibizumab (Lucentis), an anti-VEGF drug approved for the eye, at a much lower cost. Treatment involves regular eye visits and repeat injections to keep the leakage in check.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Avastin (Bevacizumab), what you've noticed, or ask the community a question.